Fulcrum
Fulcrum is a Massachusetts-based biotechnology company that develops and commercializes small molecule therapies for the treatment of genetic diseases.
Business Model:
Revenue: $10.7M
Employees: 51-200
Industries / Tags:
Detailed Fulcrum Information
Geographic Data
Address: 26 Landsdowne Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$144M
Raised Total:$403M
Social
Metrics
3,197,393Website Global Rank
4,976Website Monthly Traffic
Twitter Followers
Description
Fulcrum is a Massachusetts-based biotechnology company that develops and commercializes small molecule therapies for the treatment of genetic diseases.
Contact Phone:
+16176518851
Contact Email:
Fulcrum went public on 7/17/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/17/2019
IPO Valuation:
$372M
Ticker Symbol:
FULC
IPO Price:
$16/share
Amount Raised:
$72M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
